{"id":5809,"date":"2017-07-23T08:42:39","date_gmt":"2017-07-23T08:42:39","guid":{"rendered":"http:\/\/cobrca.org\/?page_id=5809"},"modified":"2024-08-18T09:06:17","modified_gmt":"2024-08-18T09:06:17","slug":"astrazeneca-symposium","status":"publish","type":"page","link":"https:\/\/cobrca.org\/cobrca2024\/astrazeneca-symposium\/","title":{"rendered":"AstraZeneca Symposium"},"content":{"rendered":"

Pre-Lunch Industry Symposium:
\nPush the paradigm: Advances in treating HER2-expressing metastatic breast cancer \u00a0\u00a0<\/strong><\/h3>\n

Sponsored by Daiichi Sankyo UK and AstraZeneca UK. This is a promotional symposium organised and funded by Daiichi Sankyo UK and AstraZeneca UK, at which Daiichi Sankyo and AstraZeneca products will be discussed within their UK Marketing Authorisations.
\n<\/em>UK\/ADC\/07\/24\/0032 | July 2024<\/p>\n

\"\"
\n<\/em><\/strong><\/p>\n

Thursday, September 12, 2024
\n12:30-13:30
\nHALL A<\/strong>
\n<\/strong><\/span><\/p>\n\n\n\n\n\n
12:30-12:50<\/strong><\/td>\n\n

How I manage HER2-positive metastatic breast cancer
\nJavier Cortes,<\/strong>\u00a0Madrid,<\/em>\u00a0Spain<\/em><\/p>\n<\/td>\n<\/tr>\n

12:50-13:10<\/strong><\/td>\n\n

Recent advances in HER2-expressing metastatic breast cancer treatments
\nOlga Oikonomidou, <\/strong>Edinburgh, Scotland, UK<\/em><\/p>\n<\/td>\n<\/tr>\n

13:10-13:30<\/strong>
\n<\/strong><\/td>\n		\n

Panel discussion and questions from the audience
\nJavier Cortes,<\/strong>\u00a0Madrid,<\/em> Spain
\n<\/em>Olga Oikonomidou, <\/strong>Edinburgh, Scotland, UK<\/em><\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

 <\/p>\n","protected":false},"excerpt":{"rendered":"

Pre-Lunch Industry Symposium: Push the paradigm: Advances in treating HER2-expressing metastatic breast cancer \u00a0\u00a0 Sponsored by Daiichi Sankyo UK and AstraZeneca UK. This is a promotional [\u2026]<\/span><\/p>\n","protected":false},"author":12,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-5809","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/cobrca.org\/cobrca2024\/wp-json\/wp\/v2\/pages\/5809"}],"collection":[{"href":"https:\/\/cobrca.org\/cobrca2024\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/cobrca.org\/cobrca2024\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/cobrca.org\/cobrca2024\/wp-json\/wp\/v2\/users\/12"}],"replies":[{"embeddable":true,"href":"https:\/\/cobrca.org\/cobrca2024\/wp-json\/wp\/v2\/comments?post=5809"}],"version-history":[{"count":17,"href":"https:\/\/cobrca.org\/cobrca2024\/wp-json\/wp\/v2\/pages\/5809\/revisions"}],"predecessor-version":[{"id":10178,"href":"https:\/\/cobrca.org\/cobrca2024\/wp-json\/wp\/v2\/pages\/5809\/revisions\/10178"}],"wp:attachment":[{"href":"https:\/\/cobrca.org\/cobrca2024\/wp-json\/wp\/v2\/media?parent=5809"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}